Sunday, 20 September 2020


Uscom signs deal to distribute its devices in China

15 October 2013 | News | By BioSpectrum Bureau

Distribution will commence on completion of China Food and Drug Administration approval, which is expected in 2014.

Distribution will commence on completion of China Food and Drug Administration approval, which is expected in 2014.

Singapore: Australia-based Uscom (Ultrasonic Cardiac Output Monitor) has gained a foothold into the rapidly growing Chinese medical device market after reaching an agreement with China Pioneer Pharma Holdings to distribute its cardiovascular monitoring devices.

China Pioneer, a Shanghai-based Chinese medical distribution firm with annual sales of about $260 million, has committed to minimum purchases worth about $6.6 million over five years, with target purchases of $8.3 million.

Distribution will commence on completion of China Food and Drug Administration approval, which is expected in 2014.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls